Question 1

What is the analyst consensus rating for RVMD?

Accepted Answer

The analyst consensus rating for RVMD is "Buy" based on 6 analyst recommendations.

Question 2

What is the average price target for RVMD?

Accepted Answer

The average 12-month price target for RVMD is $147.50, representing an upside of 46.6% from the current price of $100.61.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Feb 2, 2026	Brian Cheng	JP Morgan	Maintains	Buy	$92.00 → $122.00 +30.00 (32.6%)
Jan 27, 2026	Jay Olson	Oppenheimer	Maintains	Buy	$75.00 → $150.00 +75.00 (100.0%)
Jan 22, 2026	Laura Prendergast	Stifel	Maintains	Strong Buy	$85.00 → $170.00 +85.00 (100.0%)
Jan 21, 2026	Leonid Timashev	RBC Capital	Maintains	Buy	$77.00 → $140.00 +63.00 (81.8%)
Jan 20, 2026	Michael Schmidt	Guggenheim	Maintains	Strong Buy	$92.00 → $160.00 +68.00 (73.9%)
Jan 13, 2026	Joseph Catanzaro	Mizuho	Maintains	Buy	$90.00 → $143.00 +53.00 (58.9%)

Revolution Medicines (RVMD) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest RVMD Analyst Ratings & Recommendations